Mindmed appoints javier muniz, m.d., as vice president of research and development strategy

New york--(business wire)--mind medicine (mindmed) inc. (nasdaq: mnmd), (the "company" or "mindmed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of javier a. muniz, m.d., as vice president of research and development (r&d) strategy. in his new role, dr. muniz will drive innovation and growth of mindmed's r&d operations as the company prepares to initiate three phase 3 studies of mm120 or.
MNMD Ratings Summary
MNMD Quant Ranking